Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice

MLA

Matthias J. Düchs, et al. “Riboswitch-Controlled IL-12 Gene Therapy Reduces Hepatocellular Cancer in Mice.” Frontiers in Immunology, vol. 15, Mar. 2024. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1360063.

APA

Matthias J. Düchs, Ramona F. Kratzer, Pablo Vieyra-Garcia, Benjamin Strobel, Tanja Schönberger, Peter Groß, Ghaith Aljayyoussi, Aradhana Gupta, Isabel Lang, Holger Klein, Sandra Martinez Morilla, Stefan Hopf, John Park, Sebastian Kreuz, Matthias Klugmann, & Frederik H. Igney. (2024). Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1360063

Chicago

Matthias J. Düchs, Ramona F. Kratzer, Pablo Vieyra-Garcia, Benjamin Strobel, Tanja Schönberger, Peter Groß, Ghaith Aljayyoussi, et al. 2024. “Riboswitch-Controlled IL-12 Gene Therapy Reduces Hepatocellular Cancer in Mice.” Frontiers in Immunology 15 (March). doi:10.3389/fimmu.2024.1360063.